Dipeptidyl peptidase 4 as a therapeutic target in ischemia/reperfusion injury

Pharmacology and Therapeutics

Volumn 136, Issue 3, 2012, Pages 267-282

  Matheeussen, Veerle ^a   Jungraithmayr, Wolfgang ^b   De Meester, Ingrid ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

DPPIV; Glucagon like peptide 1; Hypoxia; Ischemia reperfusion injury; Stromal cell derived factor 1 alpha; Transplantation

Indexed keywords

AB 192; ALBIGLUTIDE; ATRIAL NATRIURETIC FACTOR; BI 14361; BRAIN NATRIURETIC PEPTIDE; CHEMOKINE RECEPTOR CXCR4; DIPEPTIDYL PEPTIDASE IV; DIPEPTIDYL PEPTIDASE IV INHIBITOR; DIPROTIN A; EXENDIN 4; GLUCAGON LIKE PEPTIDE 1; GRANULOCYTE COLONY STIMULATING FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 1BETA; LINAGLIPTIN; LIRAGLUTIDE; MITOGEN ACTIVATED PROTEIN KINASE; NEUROPEPTIDE Y; PHOSPHATIDYLINOSITOL 3 KINASE; SITAGLIPTIN; STROMAL CELL DERIVED FACTOR 1ALPHA; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR 1; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR 2; VILDAGLIPTIN;

ACUTE HEART INFARCTION; ARTICLE; ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DRUG MECHANISM; DRUG TARGETING; GLYCEMIC CONTROL; HEART; HEART FAILURE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; HYPOXIA; ISCHEMIA; KIDNEY ISCHEMIA; LIPID PEROXIDATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OSTEOPOROSIS; OXIDATIVE STRESS; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN TARGETING; REPERFUSION INJURY; SINGLE DRUG DOSE;

EID: 84867847993     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2012.07.012     Document Type: Review

References (217)

1. J.D. Abbott, Y. Huang, D. Liu, R. Hickey, D.S. Krause, and F.J. Giordano Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury Circulation 110 2004 3300 3305
2. W.K. Adkins, J.W. Barnard, S. May, A.F. Seibert, J. Haynes, and A.E. Taylor Compounds that increase cAMP prevent ischemia-reperfusion pulmonary capillary injury J Appl Physiol 72 1992 492 497
3. F. Alessandrini, S. Sasaki, S.I. Said, R. Lodi, and J. LoCicero III Enhancement of extended lung preservation with a vasoactive intestinal peptide-enriched University of Wisconsin solution Transplantation 59 1995 1253 1258
4. F. Alessandrini, M. Thakkar, H.D. Foda, S.I. Said, R. Lodi, and H. Pakbaz Vasoactive intestinal peptide enhances lung preservation Transplantation 56 1993 964 973
5. S. Ansorge, U. Bank, A. Heimburg, M. Helmuth, G. Koch, and J. Tadje Recent insights into the role of dipeptidyl aminopeptidase IV (DPIV) and aminopeptidase N (APN) families in immune functions Clin Chem Lab Med 47 2009 253 261
6. A. Aoyama, F. Chen, T. Fujinaga, A. Sato, T. Tsuruyama, and J. Zhang Post-ischemic infusion of atrial natriuretic peptide attenuates warm ischemia-reperfusion injury in rat lung J Heart Lung Transplant 28 2009 628 634
7. A.T. Askari, S. Unzek, Z.B. Popovic, C.K. Goldman, F. Forudi, and M. Kiedrowski Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy Lancet 362 2003 697 703
8. K. Ban, K.H. Kim, C.K. Cho, M. Sauve, E.P. Diamandis, and P.H. Backx Glucagon-like peptide (GLP)-1(9-36)amide-mediated cytoprotection is blocked by exendin(9-39) yet does not require the known GLP-1 receptor Endocrinology 151 2010 1520 1531
9. K. Ban, M.H. Noyan-Ashraf, J. Hoefer, S.S. Bolz, D.J. Drucker, and M. Husain Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways Circulation 117 2008 2340 2350
10. W. Bao, K. Aravindhan, H. Alsaid, T. Chendrimada, M. Szapacs, and D.R. Citerone Albiglutide, a long lasting glucagon-like peptide-1 analog, protects the rat heart against ischemia/reperfusion injury: evidence for improving cardiac metabolic efficiency PLoS One 6 2011 e23570
11. L. Baticic, D. Detel, N. Kucic, S. Buljevic, E.P. Pugel, and J. Varljen Neuroimmunomodulative properties of dipeptidyl peptidase IV/CD26 in a TNBS-induced model of colitis in mice J Cell Biochem 112 2011 3322 3333
12. G.F. Baxter Natriuretic peptides and myocardial ischaemia Basic Res Cardiol 99 2004 90 93
13. G.I. Bell, R. Sanchez-Pescador, P.J. Laybourn, and R.C. Najarian Exon duplication and divergence in the human preproglucagon gene Nature 304 1983 368 371
14. G.I. Bell, R.F. Santerre, and G.T. Mullenbach Hamster preproglucagon contains the sequence of glucagon and two related peptides Nature 302 1983 716 718
15. E. Berendes, C. Schmidt, H. Van Aken, M.G. Hartlage, M. Rothenburger, and S. Wirtz A-type and B-type natriuretic peptides in cardiac surgical procedures Anesth Analg 98 2004 11 19
16. A.J. Bergman, C. Stevens, Y.Y. Zhou, B.M. Yi, M. Laethem, and M. De Smet Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers Clin Ther 28 2006 55 72
17. H. Berisha, H. Foda, H. Sakakibara, M. Trotz, H. Pakbaz, and S.I. Said Vasoactive intestinal peptide prevents lung injury due to xanthine/xanthine oxidase Am J Physiol 259 1990 L151 L155
18. E. Berra, A. Ginouves, and J. Pouyssegur The hypoxia-inducible-factor hydroxylases bring fresh air into hypoxia signalling EMBO Rep 7 2006 41 45
19. A.K. Bose, M.M. Mocanu, R.D. Carr, C.L. Brand, and D.M. Yellon Glucagon-like peptide 1 can directly protect the heart against ischemia/reperfusion injury Diabetes 54 2005 146 151
20. A.K. Bose, M.M. Mocanu, R.D. Carr, and D.M. Yellon Glucagon like peptide-1 is protective against myocardial ischemia/reperfusion injury when given either as a preconditioning mimetic or at reperfusion in an isolated rat heart model Cardiovasc Drugs Ther 19 2005 9 11
21. A.K. Bose, M.M. Mocanu, R.D. Carr, and D.M. Yellon Myocardial ischaemia-reperfusion injury is attenuated by intact glucagon like peptide-1 (GLP-1) in the in vitro rat heart and may involve the p70s6K pathway Cardiovasc Drugs Ther 21 2007 253 256
22. I. Brandt, A.M. Lambeir, J.M. Ketelslegers, M. Vanderheyden, S. Scharpe, and I. De Meester Dipeptidyl-peptidase IV converts intact B-type natriuretic peptide into its des-SerPro form Clin Chem 52 2006 82 87
23. I. Brandt, A.M. Lambeir, M.B. Maes, S. Scharpe, and I. De Meester Peptide substrates of dipeptidyl peptidases Adv Exp Med Biol 575 2006 3 18
24. H.E. Broxmeyer, G. Hangoc, S. Cooper, T. Campbell, S. Ito, and C. Mantel AMD3100 and CD26 modulate mobilization, engraftment, and survival of hematopoietic stem and progenitor cells mediated by the SDF-1/CXCL12-CXCR4 axis Ann N Y Acad Sci 1106 2007 1 19
25. B.P. Bullock, R.S. Heller, and J.F. Habener Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor Endocrinology 137 1996 2968 2978
26. D.S. Burley, and G.F. Baxter B-type natriuretic peptide at early reperfusion limits infarct size in the rat isolated heart Basic Res Cardiol 102 2007 529 541
27. D.S. Burley, S.A. Hamid, and G.F. Baxter Cardioprotective actions of peptide hormones in myocardial ischemia Heart Fail Rev 12 2007 279 291
28. D.S. Burley, P. Ferdinandy, and G.F. Baxter Cyclic GMP and protein kinase-G in myocardial ischaemia-reperfusion: opportunities and obstacles for survival signaling Br J Pharmacol 152 2007 855 869
29. J.M. Burns, B.C. Summers, Y. Wang, A. Melikian, R. Berahovich, and Z. Miao A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development J Exp Med 203 2006 2201 2213
30. J.B. Buse, H.N. Ginsberg, G.L. Bakris, N.G. Clark, F. Costa, and R. Eckel Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association Circulation 115 2007 114 126
31. T.B. Campbell, G. Hangoc, Y. Liu, K. Pollok, and H.E. Broxmeyer Inhibition of CD26 in human cord blood CD34+ cells enhances their engraftment of nonobese diabetic/severe combined immunodeficiency mice Stem Cells Dev 16 2007 347 354
32. D.J. Ceradini, and G.C. Gurtner Homing to hypoxia: HIF-1 as a mediator of progenitor cell recruitment to injured tissue Trends Cardiovasc Med 15 2005 57 63
33. D.J. Ceradini, A.R. Kulkarni, M.J. Callaghan, O.M. Tepper, N. Bastidas, and M.E. Kleinman Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1 Nat Med 10 2004 858 864
34. K. Chinda, S. Palee, S. Surinkaew, M. Phornphutkul, S. Chattipakorn, and N. Chattipakorn Cardioprotective effect of dipeptidyl peptidase-4 inhibitor during ischemia-reperfusion injury Int J Cardiol 2012 10.1016/j.ijcard.2012.01. 011
35. J.D. Christie, R.M. Kotloff, V.N. Ahya, G. Tino, A. Pochettino, and C. Gaughan The effect of primary graft dysfunction on survival after lung transplantation Am J Respir Crit Care Med 171 2005 1312 1316
36. K.W. Christopherson II, G. Hangoc, and H.E. Broxmeyer Cell surface peptidase CD26/dipeptidylpeptidase IV regulates CXCL12/stromal cell-derived factor-1 alpha-mediated chemotaxis of human cord blood CD34+ progenitor cells J Immunol 169 2002 7000 7008
37. K.W. Christopherson II, G. Hangoc, C.R. Mantel, and H.E. Broxmeyer Modulation of hematopoietic stem cell homing and engraftment by CD26 Science 305 2004 1000 1003
38. K. Chujo, M. Ueki, T. Asaga, and S. Taie Atrial natriuretic peptide attenuates ischemia/reperfusion-induced renal injury by reducing neutrophil activation in rats Tohoku J Exp Med 215 2008 257 266
39. P. Covington, R. Christopher, M. Davenport, P. Fleck, Q.A. Mekki, and E.R. Wann Pharmacokinetic, pharmacodynamic, and tolerability profiles of the dipeptidyl peptidase-4 inhibitor alogliptino: a randomized, double-mind, placebo-controlled, multiple-dose study in adult patients with type 2 diabetes Clin Ther 30 2008 499 512
40. D.T. Dang, S.Y. Chun, K. Burkitt, M. Abe, S. Chen, and P. Havre Hypoxia-inducible factor-1 target genes as indicators of tumor vessel response to vascular endothelial growth factor inhibition Cancer Res 68 2008 1872 1880
41. D.K. Das, R. Kalfin, N. Maulik, and R.M. Engelman Coordinated role of vasoactive intestinal peptide and nitric oxide in cardioprotection Ann N Y Acad Sci 865 1998 297 308
42. E. De Falco, D. Porcelli, A.R. Torella, S. Straino, M.G. Iachininoto, and A. Orlandi SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells Blood 104 2004 3472 3482
43. M. De la Fuente, M. Delgado, and R.P. Gomariz VIP modulation of immune cell functions Adv Neuroimmunol 6 1996 75 91
44. C.F. Deacon Dipeptidyl peptidase-4 inhibitors in the treatment of type 2 diabetes: a comparative review Diabetes Obes Metab 13 2011 7 18
45. M. Delgado, E.J. Munoz-Elias, C. Martinez, R.P. Gomariz, and D. Ganea VIP and PACAP38 modulate cytokine and nitric oxide production in peritoneal macrophages and macrophage cell lines Ann N Y Acad Sci 897 1999 401 414
46. B.B. Dokken, L.R. La Bonte, G. Davis-Gorman, M.K. Teachey, N. Seaver, and P.F. McDonagh Glucagon-like peptide-1 (GLP-1), immediately prior to reperfusion, decreases neutrophil activation and reduces myocardial infarct size in rodents Horm Metab Res 43 2011 300 305
47. S. Domschke, W. Domschke, S.R. Bloom, P. Mitznegg, S.J. Mitchell, and G. Lux Vasoactive intestinal peptide in man: pharmacokinetics, metabolic and circulatory effects Gut 19 1978 1049 1053
48. D.J. Drucker Biological actions and therapeutic potential of the glucagon-like peptides Gastroenterology 122 2002 531 544
49. D.J. Drucker The biology of incretin hormones Cell Metab 3 2006 153 165
50. D.J. Drucker, and M.A. Nauck The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes Lancet 368 2006 1696 1705
51. S.P. D'Souza, M. Davis, and G.F. Baxter Autocrine and paracrine actions of natriuretic peptides in the heart Pharmacol Ther 101 2004 113 129
52. S.P. D'Souza, D.M. Yellon, and G.F. Baxter Cardioprotective action of type-B natriuretic peptide is NO-dependent Br J Pharmacol 138 2003 U11 U
53. S.P. D'Souza, D.M. Yellon, C. Martin, R. Schulz, G. Heusch, and A. Onody B-type natriuretic peptide limits infarct size in rat isolated hearts via KATP channel opening Am J Physiol Heart Circ Physiol 284 2003 H1592 H1600
54. T. Eckle, D. Kohler, R. Lehmann, K. El Kasmi, and H.K. Eltzschig Hypoxia-inducible factor-1 is central to cardioprotection: a new paradigm for ischemic preconditioning Circulation 118 2008 166 175
55. I. Elmadbouh, H. Haider, S. Jiang, N.M. Idris, G. Lu, and M. Ashraf Ex vivo delivered stromal cell-derived factor-1alpha promotes stem cell homing and induces angiomyogenesis in the infarcted myocardium J Mol Cell Cardiol 42 2007 792 803
56. H.K. Eltzschig, and T. Eckle Ischemia and reperfusion - from mechanism to translation Nat Med 17 2011 1391 1401
57. H.K. Eltzschig, M. Faigle, S. Knapp, J. Karhausen, J. Ibla, and P. Rosenberger Endothelial catabolism of extracellular adenosine during hypoxia: the role of surface adenosine deaminase and CD26 Blood 108 2006 1602 1610
58. G.P. Fadini, E. Boscaro, M. Albiero, L. Menegazzo, V. Frison, and S. de Kreutzenberg The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: possible role of stromal-derived factor-1alpha Diabetes Care 33 2010 1607 1609
59. R. Frederich, J.H. Alexander, F.T. Fiedorek, M. Donovan, N. Berglind, and S. Harris A systematic assessment of cardiovascular outcomes in the saxagliptin drug development program for type 2 diabetes Postgrad Med 122 2010 16 27
60. A.C. Girardi, L.E. Fukuda, L.V. Rossoni, G. Malnic, and N.A. Reboucas Dipeptidyl peptidase IV inhibition downregulates Na+-H+ exchanger NHE3 in rat renal proximal tubule Am J Physiol Renal Physiol 294 2008 F414 F422
61. A.C. Girardi, F. Knauf, H.U. Demuth, and P.S. Aronson Role of dipeptidyl peptidase IV in regulating activity of Na+/H+ exchanger isoform NHE3 in proximal tubule cells Am J Physiol Cell Physiol 287 2004 C1238 C1245
62. L.L. Glorie, A. Verhulst, V. Matheeussen, L. Baerts, J. Magielse, and N. Hermans DPP4 inhibition improves functional outcome after renal ischemia reperfusion injury Am J Physiol Renal Physiol 2012 10.1152/ajprenal.00075.2012
63. H.A. Golpon, A. Puechner, T. Welte, P.V. Wichert, and C.O. Feddersen Vasorelaxant effect of glucagon-like peptide-(7-36)amide and amylin on the pulmonary circulation of the rat Regul Pept 102 2001 81 86
64. N. Gomez, K. Touihri, V. Matheeussen, A. Mendes Da Costa, M. Mahmoudabady, and M. Mathieu Dipeptidyl peptidase IV inhibition improves cardiorenal function in overpacing-induced heart failure Eur J Heart Fail 14 2012 14 21
65. A. Gorbe, Z. Giricz, A. Szunyog, T. Csont, D.S. Burley, and G.F. Baxter Role of cGMP-PKG signaling in the protection of neonatal rat cardiac myocytes subjected to simulated ischemia/reoxygenation Basic Res Cardiol 105 2010 643 650
66. D.N. Granger, and R.J. Korthuis Physiologic mechanisms of postischemic tissue injury Annu Rev Physiol 57 1995 311 332
67. D.J. Grieve, R.S. Cassidy, and B.D. Green Emerging cardiovascular actions of the incretin hormone glucagon-like peptide-1: potential therapeutic benefits beyond glycaemic control? Br J Pharmacol 157 2009 1340 1351
68. D.A. Groneberg, K.F. Rabe, and A. Fischer Novel concepts of neuropeptide-based drug therapy: vasoactive intestinal polypeptide and its receptors Eur J Pharmacol 533 2006 182 194
69. M. Gyongyosi, J. Kaszaki, J. Nemeth, A. Wolfard, L. Mojzes, and A. Farkas Myocardial and gastrointestinal release of vasoactive intestinal peptide during experimental acute myocardial infarction Coron Artery Dis 8 1997 335 341
70. M. Gyongyosi, J. Nemeth, and T. Varkonyi Elevated levels of plasma vasoactive intestinal peptide in human acute myocardial infarction Int J Cardiol 56 1996 159 161
71. D.J. Hausenloy, G. Baxter, R. Bell, H.E. Botker, S.M. Davidson, and J. Downey Translating novel strategies for cardioprotection: the Hatter Workshop Recommendations Basic Res Cardiol 105 2010 677 686
72. D.J. Hausenloy, and D.M. Yellon New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway Cardiovasc Res 61 2004 448 460
73. Y.L. He, R. Sabo, J. Campestrini, Y. Wang, G.J. Riviere, and J.C. Nielsen The effect of age, gender, and body mass index on the pharmacokinetics and pharmacodynamics of vildagliptin in healthy volunteers Br J Clin Pharmacol 65 2008 338 346
74. T. Heise, E.U. Graefe-Mody, S. Huttner, A. Ring, D. Trommeshauser, and K.A. Dugi Pharmacokinetics, pharmacodynamics and tolerability of multiple oral doses of linagliptin, a dipeptidyl peptidase-4 inhibitor in male type 2 diabetes patients Diabetes Obes Metab 11 2009 786 794
75. R.J. Henning, and D.R. Sawmiller Vasoactive intestinal peptide: cardiovascular effects Cardiovasc Res 49 2001 27 37
76. C. Herrera, C. Morimoto, J. Blanco, J. Mallol, F. Arenzana, and C. Lluis Comodulation of CXCR4 and CD26 in human lymphocytes J Biol Chem 276 2001 19532 19539
77. K. Hiasa, M. Ishibashi, K. Ohtani, S. Inoue, Q. Zhao, and S. Kitamoto Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization Circulation 109 2004 2454 2461
78. W. Hiesinger, J.R. Frederick, P. Atluri, R.C. McCormick, N. Marotta, and J.R. Muenzer Spliced stromal cell-derived factor-1alpha analog stimulates endothelial progenitor cell migration and improves cardiac function in a dose-dependent manner after myocardial infarction J Thorac Cardiovasc Surg 140 2010 1174 1180
79. W.D. Hill, D.C. Hess, A. Martin-Studdard, J.J. Carothers, J. Zheng, and D. Hale SDF-1 (CXCL12) is upregulated in the ischemic penumbra following stroke: association with bone marrow cell homing to injury J Neuropathol Exp Neurol 63 2004 84 96
80. P. Hill, D. Shukla, M.G. Tran, J. Aragones, H.T. Cook, and P. Carmeliet Inhibition of hypoxia inducible factor hydroxylases protects against renal ischemia-reperfusion injury J Am Soc Nephrol 19 2008 39 46
81. B. Hocher, Y. Sharkovska, M. Mark, T. Klein, and T. Pfab The novel DPP-4 inhibitors linagliptin and BI 14361 reduce infarct size after myocardial ischemia/reperfusion in rats Int J Cardiol 2012 10.1016/j.ijcard.2011.12.007
82. S.C. Hoffmann, M.S. Bleiweis, D.R. Jones, H.C. Paik, P. Ciriaco, and T.M. Egan Maintenance of cAMP in non-heart-beating donor lungs reduces ischemia-reperfusion injury Am J Respir Crit Care Med 163 2001 1642 1647
83. X. Hu, S. Dai, W.J. Wu, W. Tan, X. Zhu, and J. Mu Stromal cell derived factor-1 alpha confers protection against myocardial ischemia/reperfusion injury: role of the cardiac stromal cell derived factor-1 alpha CXCR4 axis Circulation 116 2007 654 663
84. B.C. Huber, S. Brunner, A. Segeth, P. Nathan, R. Fischer, and M.M. Zaruba Parathyroid hormone is a DPP-IV inhibitor and increases SDF-1-driven homing of CXCR4(+) stem cells into the ischaemic heart Cardiovasc Res 90 2011 529 537
85. B. Huisamen, S. Genade, and A. Lochner Signalling pathways activated by glucagon-like peptide-1 (7-36) amide in the rat heart and their role in protection against ischaemia Cardiovasc J Afr 19 2008 77 83
86. B. Huisamen, A. Genis, E. Marais, and A. Lochner Pre-treatment with a DPP-4 inhibitor is infarct sparing in hearts from obese, pre-diabetic rats Cardiovasc Drugs Ther 25 2011 13 20
87. K.A. Jackson, S.M. Majka, H. Wang, J. Pocius, C.J. Hartley, and M.W. Majesky Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells J Clin Invest 107 2001 1395 1402
88. W. Jiang, W. Tang, Q. Geng, and X. Xu Inhibition of Toll-like receptor 4 with vasoactive intestinal peptide attenuates liver ischemia-reperfusion injury Transplant Proc 43 2011 1462 1467
89. D.K. Jin, K. Shido, H.G. Kopp, I. Petit, S.V. Shmelkov, and L.M. Young Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes Nat Med 12 2006 557 567
90. W. Jungraithmayr, I. De Meester, V. Matheeussen, L. Baerts, S. Arni, and W. Weder CD26/DPP-4 inhibition recruits regenerative stem cells via stromal cell-derived factor-1 and beneficially influences ischaemia-reperfusion injury in mouse lung transplantation Eur J Cardiothorac Surg 41 2012 1166 1173
91. W. Jungraithmayr, I. De Meester, V. Matheeussen, I. Inci, K. Augustyns, and S. Scharpe Inhibition of CD26/DPP IV attenuates ischemia/reperfusion injury in orthotopic mouse lung transplants: the pivotal role of vasoactive intestinal peptide Peptides 31 2010 585 591
92. L. Kaijser, J. Pernow, B. Berglund, and J.M. Lundberg Neuropeptide Y is released together with noradrenaline from the human heart during exercise and hypoxia Clin Physiol 10 1990 179 188
93. S. Kale, A. Karihaloo, P.R. Clark, M. Kashgarian, D.S. Krause, and L.G. Cantley Bone marrow stem cells contribute to repair of the ischemically injured renal tubule J Clin Invest 112 2003 42 49
94. R. Kalfin, N. Maulik, R.M. Engelman, G.A. Cordis, K. Milenov, and L. Kasakov Protective role of intracoronary vasoactive intestinal peptide in ischemic and reperfused myocardium J Pharmacol Exp Ther 268 1994 952 958
95. H. Kamihata, H. Matsubara, T. Nishiue, S. Fujiyama, Y. Tsutsumi, and R. Ozono Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines Circulation 104 2001 1046 1052
96. S. Kanki, V.F. Segers, W. Wu, R. Kakkar, J. Gannon, and S.U. Sys Stromal cell-derived factor-1 retention and cardioprotection for ischemic myocardium Circ Heart Fail 4 2011 509 518
97. T. Karagiannis, P. Paschos, K. Paletas, D.R. Matthews, and A. Tsapas Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis BMJ 344 2012 e1369
98. M. Kavianipour, M.R. Ehlers, K. Malmberg, G. Ronquist, L. Ryden, and G. Wikstrom Glucagon-like peptide-1 (7-36) amide prevents the accumulation of pyruvate and lactate in the ischemic and non-ischemic porcine myocardium Peptides 24 2003 569 578
99. A. Kawamoto, T. Tkebuchava, J. Yamaguchi, H. Nishimura, Y.S. Yoon, and C. Milliken Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia Circulation 107 2003 461 468
100. A.J. Kenny, A.G. Booth, E.J. Wood, and A.R. Young Dipeptidyl peptidase IV, a kidney microvillus serine proteinase: evidence for its large subunit molecular weight and endopeptidase activity Biochem Soc Trans 4 1976 347 348
101. T. Kim, P.K. Harman, R. Lyons, R.B. Gaskins III, C.E. Hobson, and S.M. Evans Brain natriuretic peptide is not reno-protective during renal ischemia-reperfusion injury in the rat J Surg Res 164 2010 e13 e19
102. J. Kitlinska, E.W. Lee, L. Li, J. Pons, L. Estes, and Z. Zukowska Dual role of dipeptidyl peptidase IV (DPP IV) in angiogenesis and vascular remodeling Adv Exp Med Biol 524 2003 215 222
103. A.A. Kocher, M.D. Schuster, M.J. Szabolcs, S. Takuma, D. Burkhoff, and J. Wang Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function Nat Med 7 2001 430 436
104. H. Koga, S. Hagiwara, J. Kusaka, S. Matsumoto, T. Nishida, and I. Yokoi Human atrial natriuretic peptide attenuates renal ischemia-reperfusion injury J Surg Res 173 2012 328 353
105. P.A. Krijnen, N.E. Hahn, I. Kholova, U. Baylan, J.A. Sipkens, and F.P. van Alphen Loss of DPP4 activity is related to a prothrombogenic status of endothelial cells: implications for the coronary microvasculature of myocardial infarction patients Basic Res Cardiol 107 2011 1 13
106. J. Kristensen, U.M. Mortensen, M. Schmidt, P.H. Nielsen, T.T. Nielsen, and M. Maeng Lack of cardioprotection from subcutaneously and preischemic administered liraglutide in a closed chest porcine ischemia reperfusion model BMC Cardiovasc Disord 9 2009 31
107. H.C. Ku, W.P. Chen, and M.J. Su DPP4 deficiency preserves cardiac function via GLP-1 signaling in rats subjected to myocardial ischemia/reperfusion Naunyn Schmiedebergs Arch Pharmacol 384 2011 197 207
108. L.E. Kuo, K. Abe, and Z. Zukowska Stress, NPY and vascular remodeling: implications for stress-related diseases Peptides 28 2007 435 440
109. K.A. Kyle, T.L. Willett, L.L. Baggio, D.J. Drucker, and M.D. Grynpas Differential effects of PPAR-{gamma} activation versus chemical or genetic reduction of DPP-4 activity on bone quality in mice Endocrinology 152 2011 457 467
110. A.M. Lambeir, C. Durinx, P. Proost, J. Van Damme, S. Scharpe, and I. De Meester Kinetic study of the processing by dipeptidyl-peptidase IV/CD26 of neuropeptides involved in pancreatic insulin secretion FEBS Lett 507 2001 327 330
111. A.M. Lambeir, C. Durinx, S. Scharpe, and I. De Meester Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV Crit Rev Clin Lab Sci 40 2003 209 294
112. A.M. Lambeir, S. Scharpé, and I. De Meester DPP4 inhibitors for diabetes - what next? Biochem Pharmacol 76 2008 1637 1643
113. E.W. Lee, M. Michalkiewicz, J. Kitlinska, I. Kalezic, H. Switalska, and P. Yoo Neuropeptide Y induces ischemic angiogenesis and restores function of ischemic skeletal muscles J Clin Invest 111 2003 1853 1862
114. I. Leister, E.M. Mbachu, S. Post, S.T. Samel, T. Stojanovic, and C.N. Gutt Vasoactive intestinal polypeptide and gastrin-releasing peptide attenuate hepatic microvasculatory disturbances following intestinal ischemia and reperfusion Digestion 66 2002 186 192
115. J.M. Liebler, C. Lutzko, A. Banfalvi, D. Senadheera, N. Aghamohammadi, and E.D. Crandall Retention of human bone marrow-derived cells in murine lungs following bleomycin-induced lung injury Am J Physiol Lung Cell Mol Physiol 295 2008 L285 L292
116. F. Lin, K. Cordes, L. Li, L. Hood, W.G. Couser, and S.J. Shankland Hematopoietic stem cells contribute to the regeneration of renal tubules after renal ischemia-reperfusion injury in mice J Am Soc Nephrol 14 2003 1188 1199
117. D.K. Litwin, A.K. Wilson, and S.I. Said Vasoactive intestinal polypeptide (VIP) inhibits rat alveolar macrophage phagocytosis and chemotaxis in vitro Regul Pept 40 1992 63 74
118. H. Liu, S. Liu, Y. Li, X. Wang, W. Xue, and G. Ge The role of SDF-1-CXCR4/CXCR7 axis in the therapeutic effects of hypoxia-preconditioned mesenchymal stem cells for renal ischemia/reperfusion injury PLoS One 7 2012 e34608
119. J. Lonborg, N. Vejlstrup, H. Kelbaek, H.E. Botker, W.Y. Kim, and A.B. Mathiasen Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction Eur Heart J 33 2012 1491 1499
120. L.C. Lopez, M.L. Frazier, C.J. Su, A. Kumar, and G.F. Saunders Mammalian pancreatic preproglucagon contains three glucagon-related peptides Proc Natl Acad Sci U S A 80 1983 5485 5489
121. P. Lucia, S. Caiola, A. Coppola, E. Maroccia, M. Belli, and A. Buongiorno Early increase of vasoactive intestinal peptide in acute myocardial infarction Am Heart J 132 1996 187 189
122. P. Lucia, S. Caiola, A. Coppola, E. Maroccia, M. Belli, and C. De Martinis Effect of age and relation to mortality on serial changes of vasoactive intestinal peptide in acute myocardial infarction Am J Cardiol 77 1996 644 646
123. J. Ma, J. Ge, S. Zhang, A. Sun, J. Shen, and L. Chen Time course of myocardial stromal cell-derived factor 1 expression and beneficial effects of intravenously administered bone marrow stem cells in rats with experimental myocardial infarction Basic Res Cardiol 100 2005 217 223
124. A.A. Mangi, N. Noiseux, D. Kong, H. He, M. Rezvani, and J.S. Ingwall Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts Nat Med 9 2003 1195 1201
125. V. Matheeussen, L. Baerts, G. De Meyer, G. De Keulenaer, P. Van der Veken, and K. Augustyns Expression and spatial heterogeneity of dipeptidyl peptidases in endothelial cells of conduct vessels and capillaries Biol Chem 392 2011 189 198
126. M. Matsubara, S. Kanemoto, B.G. Leshnower, E.F. Albone, R. Hinmon, and T. Plappert Single dose GLP-1-Tf ameliorates myocardial ischemia/reperfusion injury J Surg Res 165 2011 38 45
127. J. Matsubara, S. Sugiyama, K. Sugamura, T. Nakamura, Y. Fujiwara, and E. Akiyama A dipeptidyl peptidase-4 inhibitor, des-fluoro-sitagliptin, improves endothelial function and reduces atherosclerotic lesion formation in apolipoprotein E-deficient mice J Am Coll Cardiol 59 2012 265 276
128. B. Mazzinghi, E. Ronconi, E. Lazzeri, C. Sagrinati, L. Ballerini, and M.L. Angelotti Essential but differential role for CXCR4 and CXCR7 in the therapeutic homing of human renal progenitor cells J Exp Med 205 2008 479 490
129. R. Mentlein, P. Dahms, D. Grandt, and R. Kruger Proteolytic processing of neuropeptide Y and peptide YY by dipeptidyl peptidase IV Regul Pept 49 1993 133 144
130. R. Mentlein, B. Gallwitz, and W.E. Schmidt Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum Eur J Biochem 214 1993 829 835
131. B.R. Misra, and H.P. Misra Vasoactive intestinal peptide, a singlet oxygen quencher J Biol Chem 265 1990 15371 15374
132. M. Monami, I. Dicembrini, D. Martelli, and E. Mannucci Safety of dipeptidyl peptidase-4 inhibitors: a meta-analysis of randomized clinical trials Curr Med Res Opin 27 Suppl. 3 2011 57 64
133. P.J. Moro, J. Quilici, R. Giorgi, T. Cuisset, Y. By, and A. Boussuges Mononuclear cell adenosine deaminase and CD26/dipeptidylpeptidase-IV activities are sensitive markers of reperfusion during percutaneous transluminal angioplasty Int J Cardiol 2011 10.1016/j.ijcard.2011.10.090
134. S. Movafagh, J.P. Hobson, S. Spiegel, H.K. Kleinman, and Z. Zukowska Neuropeptide Y induces migration, proliferation, and tube formation of endothelial cells bimodally via Y1, Y2, and Y5 receptors FASEB J 20 2006 1924 1926
135. C.E. Murry, M.H. Soonpaa, H. Reinecke, H. Nakajima, H.O. Nakajima, and M. Rubart Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts Nature 428 2004 664 668
136. I. Nagahiro, M. Yano, C.H. Boasquevisque, S. Fujino, J.D. Cooper, and G.A. Patterson Vasoactive intestinal peptide ameliorates reperfusion injury in rat lung transplantation J Heart Lung Transplant 17 1998 617 621
137. M.G. Narducci, E. Scala, A. Bresin, E. Caprini, M.C. Picchio, and D. Remotti Skin homing of Sezary cells involves SDF-1-CXCR4 signaling and down-regulation of CD26/dipeptidylpeptidase IV Blood 107 2006 1108 1115
138. B. Nervi, D.C. Link, and J.F. DiPersio Cytokines and hematopoietic stem cell mobilization J Cell Biochem 99 2006 690 705
139. L.A. Nikolaidis, A. Doverspike, T. Hentosz, L. Zourelias, Y.T. Shen, and D. Elahi Glucagon-like peptide-1 limits myocardial stunning following brief coronary occlusion and reperfusion in conscious canines J Pharmacol Exp Ther 312 2005 303 308
140. L.A. Nikolaidis, S. Mankad, G.G. Sokos, G. Miske, A. Shah, and D. Elahi Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion Circulation 109 2004 962 965
141. M.H. Noyan-Ashraf, M.A. Momen, K. Ban, A.M. Sadi, Y.Q. Zhou, and A.M. Riazi GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice Diabetes 58 2009 975 983
142. T. Nystrom, M.K. Gutniak, Q. Zhang, F. Zhang, J.J. Holst, and B. Ahren Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease Am J Physiol Endocrinol Metab 287 2004 E1209 E1215
143. H. Ohnishi, S. Mizuno, and T. Nakamura Inhibition of tubular cell proliferation by neutralizing endogenous HGF leads to renal hypoxia and bone marrow-derived cell engraftment in acute renal failure Am J Physiol Renal Physiol 294 2008 F326 F335
144. S. Onoue, S. Misaka, and S. Yamada Structure-activity relationship of vasoactive intestinal peptide (VIP): potent agonists and potential clinical applications Naunyn Schmiedebergs Arch Pharmacol 377 2008 579 590
145. D. Orlic, J. Kajstura, S. Chimenti, I. Jakoniuk, S.M. Anderson, and B. Li Bone marrow cells regenerate infarcted myocardium Nature 410 2001 701 705
146. D. Orlic, J. Kajstura, S. Chimenti, F. Limana, I. Jakoniuk, and F. Quaini Mobilized bone marrow cells repair the infarcted heart, improving function and survival Proc Natl Acad Sci U S A 98 2001 10344 10349
147. A. Ossum, U. van Deurs, T. Engstrom, J.S. Jensen, and M. Treiman The cardioprotective and inotropic components of the postconditioning effects of GLP-1 and GLP-1(9-36)a in an isolated rat heart Pharmacol Res 60 2009 411 417
148. H. Pakbaz, H.D. Foda, H.I. Berisha, M. Trotz, and S.I. Said Paraquat-induced lung injury - prevention by vasoactive-intestinal-peptide and related peptide helodermin Am J Physiol 265 1993 L369 L373
149. I. Petit, M. Szyper-Kravitz, A. Nagler, M. Lahav, A. Peled, and L. Habler G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4 Nat Immunol 3 2002 687 694
150. K. Pillarisetti, and S.K. Gupta Cloning and relative expression analysis of rat stromal cell derived factor-1 (SDF-1)1: SDF-1 alpha mRNA is selectively induced in rat model of myocardial infarction Inflammation 25 2001 293 300
151. S. Post, A.M. Smits, A.J. van den Broek, J.P. Sluijter, I.E. Hoefer, and B.J. Janssen Impaired recruitment of HHT-1 mononuclear cells to the ischaemic heart is due to an altered CXCR4/CD26 balance Cardiovasc Res 85 2010 494 502
152. M.C. Poznansky, I.T. Olszak, R. Foxall, R.H. Evans, A.D. Luster, and D.T. Scadden Active movement of T cells away from a chemokine Nat Med 6 2000 543 548
153. P.A. Read, F.Z. Khan, P.M. Heck, S.P. Hoole, and D.P. Dutka DPP-4
154. B. Ren, Y. Shen, H. Shao, J. Qian, H. Wu, and H. Jing Brain natriuretic peptide limits myocardial infarct size dependent of nitric oxide synthase in rats Clin Chim Acta 377 2007 83 87
155. B. Ren, H. Wu, R. Yin, L. Xu, H. Jing, and M. Li B-type natriuretic peptide pretreatment attenuates heart ischemia-reperfusion injury in rats Transplant Proc 42 2010 4496 4498
156. G. Richter, O. Feddersen, U. Wagner, P. Barth, R. Goke, and B. Goke GLP-1 stimulates secretion of macromolecules from airways and relaxes pulmonary artery Am J Physiol 265 1993 L374 L381
157. M.P. Robich, R. Matyal, L.M. Chu, J. Feng, S.H. Xu, and R.J. Laham Effects of neuropeptide Y on collateral development in a swine model of chronic myocardial ischemia J Mol Cell Cardiol 49 2010 1022 1030
158. K. Rosenkranz, S. Kumbruch, K. Lebermann, K. Marschner, A. Jensen, and R. Dermietzel The chemokine SDF-1/CXCL12 contributes to the 'homing' of umbilical cord blood cells to a hypoxic-ischemic lesion in the rat brain J Neurosci Res 88 2010 1223 1233
159. P. Ruiz, N. Zacharievich, A.L. Viciana, and M. Shenkin Peripheral CD34+ progenitor cells express CD26 and contain increased dipeptidyl peptidase IV activity Acta Haematol 100 1998 110 112
160. M.S. Sabatine, D.A. Morrow, J.A. de Lemos, T. Omland, M.Y. Desai, and M. Tanasijevic Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia J Am Coll Cardiol 44 2004 1988 1995
161. S.I. Said, and V. Mutt Polypeptide with broad biological activity: isolation from small intestine Science 169 1970 1217 1218
162. M. Sauvé, K. Ban, M.A. Momen, Y.Q. Zhou, R.M. Henkelman, and M. Husain Genetic deletion or pharmacological inhibition of dipeptidyl peptidase-4 improves cardiovascular outcomes after myocardial infarction in mice Diabetes 59 2010 1063 1073
163. D.R. Sawmiller, M. Ashtari, H. Urueta, M. Leschinsky, and R.J. Henning Mechanisms of vasoactive intestinal peptide-elicited coronary vasodilation in the isolated perfused rat heart Neuropeptides 40 2006 349 355
164. D.R. Sawmiller, R.J. Henning, J. Cuevas, W.I. Dehaven, and D.L. Vesely Coronary vascular effects of vasoactive intestinal peptide in the isolated perfused rat heart Neuropeptides 38 2004 289 297
165. A. Saxena, J.E. Fish, M.D. White, S. Yu, J.W. Smyth, and R.M. Shaw Stromal cell-derived factor-1alpha is cardioprotective after myocardial infarction Circulation 117 2008 2224 2231
166. J. Schade, M. Stephan, A. Schmiedl, L. Wagner, A.J. Niestroj, and H.U. Demuth Regulation of expression and function of dipeptidyl peptidase 4 (DP4), DP8/9, and DP10 in allergic responses of the lung in rats J Histochem Cytochem 56 2008 147 155
167. N.C. Schaper, and B. Havekes Diabetes: impaired damage control Diabetologia 55 2012 18 20
168. T. Schioppa, B. Uranchimeg, A. Saccani, S.K. Biswas, A. Doni, and A. Rapisarda Regulation of the chemokine receptor CXCR4 by hypoxia J Exp Med 198 2003 1391 1402
169. A. Schuh, A. Kroh, S. Konschalla, E.A. Liehn, R.M. Sobota, and E.A. Biessen Myocardial regeneration by transplantation of modified endothelial progenitor cells expressing SDF-1 in a rat model J Cell Mol Med 2012 10.1111/j.1582-4934.2012.01539.x
170. E. Schwaiger, C. Klaus, V. Matheeussen, U. Baranyi, N. Pilat, and H. Ramsey Dipeptidyl peptidase IV (DPPIV/CD26) inhibition does not improve engraftment of unfractionated syngeneic or allogeneic bone marrow after non-myeloablative conditioning Exp Hematol 40 2012 97 106
171. V.F. Segers, T. Tokunou, L.J. Higgins, C. MacGillivray, J. Gannon, and R.T. Lee Local delivery of protease-resistant stromal cell derived factor-1 for stem cell recruitment after myocardial infarction Circulation 116 2007 1683 1692
172. Z. Shah, T. Kampfrath, J.A. Deiuliis, J. Zhong, C. Pineda, and Z. Ying Long-term dipeptidyl-peptidase 4 inhibition reduces atherosclerosis and inflammation via effects on monocyte recruitment and chemotaxis Circulation 124 2011 2338 2349
173. M. Shirozu, T. Nakano, J. Inazawa, K. Tashiro, H. Tada, and T. Shinohara Structure and chromosomal localization of the human stromal cell-derived factor 1 (SDF1) gene Genomics 28 1995 495 500
174. J.S. Skyler, R. Bergenstal, R.O. Bonow, J. Buse, P. Deedwania, and E.A. Gale Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association J Am Coll Cardiol 53 2009 298 304
175. D.P. Sonne, T. Engstrom, and M. Treiman Protective effects of GLP-1 analogues exendin-4 and GLP-1(9-36) amide against ischemia-reperfusion injury in rat heart Regul Pept 146 2008 243 249
176. G. Stokman, I. Stroo, N. Claessen, G.J. Teske, S. Florquin, and J.C. Leemans SDF-1 provides morphological and functional protection against renal ischaemia/reperfusion injury Nephrol Dial Transplant 25 2010 3852 3859
177. I. Stroo, G. Stokman, G.J. Teske, S. Florquin, and J.C. Leemans Haematopoietic stem cell migration to the ischemic damaged kidney is not altered by manipulating the SDF-1/CXCR4-axis Nephrol Dial Transplant 24 2009 2082 2088
178. Y. Sun, T. Deng, N. Lu, M. Yan, and X. Zheng B-type natriuretic peptide protects cardiomyocytes at reperfusion via mitochondrial calcium uniporter Biomed Pharmacother 64 2010 170 176
179. Y. Sun, Y. Zhang, M. Yan, Y. Wu, and X. Zheng B-type natriuretic peptide-induced cardioprotection against reperfusion is associated with attenuation of mitochondrial permeability transition Biol Pharm Bull 32 2009 1545 1551
180. N.N. Ta, C.A. Schuyler, Y. Li, M.F. Lopes-Virella, and Y. Huang DPP-4 (CD26) inhibitor alogliptin inhibits atherosclerosis in diabetic apolipoprotein E-deficient mice J Cardiovasc Pharmacol 58 2011 157 166
181. M. Takahashi Role of the SDF-1/CXCR4 system in myocardial infarction Circ J 74 2010 418 423
182. Y.L. Tang, K. Qian, Y.C. Zhang, L. Shen, and M.I. Phillips Mobilizing of haematopoietic stem cells to ischemic myocardium by plasmid mediated stromal-cell-derived factor-1alpha (SDF-1alpha) treatment Regul Pept 125 2005 1 8
183. J. Tang, J. Wang, J. Yang, X. Kong, F. Zheng, and L. Guo Mesenchymal stem cells over-expressing SDF-1 promote angiogenesis and improve heart function in experimental myocardial infarction in rats Eur J Cardiothorac Surg 36 2009 644 650
184. M. Terasaki, M. Nagashima, T. Watanabe, K. Nohtomi, Y. Mori, and A. Miyazaki Effects of PKF275-055, a dipeptidyl peptidase-4 inhibitor, on the development of atherosclerotic lesions in apolipoprotein E-null mice Metabolism 61 2012 974 977
185. H.D. Theiss, C. Brenner, M.G. Engelmann, M.M. Zaruba, B. Huber, and V. Henschel Safety and efficacy of SITAgliptin plus GRanulocyte-colony-stimulating factor in patients suffering from Acute Myocardial Infarction (SITAGRAMI-Trial) - rationale, design and first interim analysis Int J Cardiol 145 2010 282 284
186. H.D. Theiss, M. Vallaster, C. Rischpler, L. Krieg, M.M. Zaruba, and S. Brunner Dual stem cell therapy after myocardial infarction acts specifically by enhanced homing via the SDF-1/CXCR4 axis Stem Cell Res 7 2011 244 255
187. L. Timmers, J.P. Henriques, D.P. de Kleijn, J.H. Devries, H. Kemperman, and P. Steendijk Exenatide reduces infarct size and improves cardiac function in a porcine model of ischemia and reperfusion injury J Am Coll Cardiol 53 2009 501 510
188. F. Tögel, J. Isaac, Z. Hu, K. Weiss, and C. Westenfelder Renal SDF-1 signals mobilization and homing of CXCR4-positive cells to the kidney after ischemic injury Kidney Int 67 2005 1772 1784
189. C. Toma, M.F. Pittenger, K.S. Cahill, B.J. Byrne, and P.D. Kessler Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart Circulation 105 2002 93 98
190. V.V. Upreti, D.W. Boulton, L. Li, A. Ching, H. Su, and F.P. LaCreta Effect of rifampicin on the pharmacokinetics and pharmacodynamics of saxagliptin, a dipeptidyl peptidase-4 inhibitor, in healthy subjects Br J Clin Pharmacol 72 2011 92 102
191. J.R. Ussher, and D.J. Drucker Cardiovascular biology of the incretin system Endocr Rev 33 2012 187 215
192. J.D. Vaghasiya, N.R. Sheth, Y.S. Bhalodia, and N.P. Jivani Exaggerated liver injury induced by renal ischemia reperfusion in diabetes: effect of exenatide Saudi J Gastroenterol 16 2010 174 180
193. J. Vaghasiya, N. Sheth, Y. Bhalodia, and R. Manek Sitagliptin protects renal ischemia reperfusion induced renal damage in diabetes Regul Pept 166 2011 48 54
194. H. Wald, H. Markowitz, S. Zevin, and M.M. Popovtzer Opposite effects of diabetes on nephrotoxic and ischemic acute tubular necrosis Proc Soc Exp Biol Med 195 1990 51 56
195. C.H. Wang, W.J. Cherng, N.I. Yang, C.M. Hsu, C.H. Yeh, and Y.J. Lan Cyclosporine increases ischemia-induced endothelial progenitor cell mobilization through manipulation of the CD26 system Am J Physiol Regul Integr Comp Physiol 294 2008 R811 R818
196. Y. Wang, Y. Deng, and G.Q. Zhou SDF-1alpha/CXCR4-mediated migration of systemically transplanted bone marrow stromal cells towards ischemic brain lesion in a rat model Brain Res 1195 2008 104 112
197. C.H. Wang, S. Verma, I.C. Hsieh, Y.J. Chen, L.T. Kuo, and N.I. Yang Enalapril increases ischemia-induced endothelial progenitor cell mobilization through manipulation of the CD26 system J Mol Cell Cardiol 41 2006 34 43
198. Y. Wang, D. Zhang, M. Ashraf, T. Zhao, W. Huang, and A. Ashraf Combining neuropeptide Y and mesenchymal stem cells reverses remodeling after myocardial infarction Am J Physiol Heart Circ Physiol 298 2010 H275 H286
199. G. Warnecke Lung transplantation research: impact of a new surgical model Eur J Cardiothorac Surg 41 2012 1173 1174
200. Y. Wei, and S. Mojsov Tissue-specific expression of the human receptor for glucagon-like peptide-I: brain, heart and pancreatic forms have the same deduced amino acid sequences FEBS Lett 358 1995 219 224
201. Y. Wei, and S. Mojsov Distribution of GLP-1 and PACAP receptors in human tissues Acta Physiol Scand 157 1996 355 357
202. B. Wu, H. Jiang, R. Lin, B. Cui, H. Wen, and Z. Lu Pretreatment with B-type natriuretic peptide protects the heart from ischemia-reperfusion injury by inhibiting myocardial apoptosis Tohoku J Exp Med 219 2009 107 114
203. Y. Xie, S.X. Wang, W.W. Sha, X. Zhou, W.L. Wang, and L.P. Han Effects and mechanism of glucagon-like peptide-1 on injury of rats cardiomyocytes induced by hypoxia-reoxygenation Chin Med J (Engl) 121 2008 2134 2138
204. J. Yamaguchi, K.F. Kusano, O. Masuo, A. Kawamoto, M. Silver, and S. Murasawa Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization Circulation 107 2003 1322 1328
205. Y. Ye, K.T. Keyes, C. Zhang, J.R. Perez-Polo, Y. Lin, and Y. Birnbaum The myocardial infarct size-limiting effect of sitagliptin is PKA-dependent, whereas the protective effect of pioglitazone is partially dependent on PKA Am J Physiol Heart Circ Physiol 298 2010 H1454 H1465
206. Y. Ye, J.R. Perez-Polo, D. Aguilar, and Y. Birnbaum The potential effects of anti-diabetic medications on myocardial ischemia-reperfusion injury Basic Res Cardiol 106 2011 925 952
207. M. Yin, H.H. Sillje, M. Meissner, W.H. van Gilst, and R.A. de Boer Early and late effects of the DPP-4 inhibitor vildagliptin in a rat model of post-myocardial infarction heart failure Cardiovasc Diabetol 10 2011 85
208. M.M. Zaruba, H.D. Theiss, M. Vallaster, U. Mehl, S. Brunner, and R. David Synergy between CD26/DPP-IV inhibition and G-CSF improves cardiac function after acute myocardial infarction Cell Stem Cell 4 2009 313 323
209. W. Zhai, M. Cardell, I. De Meester, K. Augustyns, S. Hillinger, and I. Inci Ischemia/reperfusion injury: the role of CD26/dipeptidyl-peptidase-IV- inhibition in lung transplantation Transplant Proc 38 2006 3369 3371
210. W. Zhai, M. Cardell, I. De Meester, K. Augustyns, S. Hillinger, and I. Inci Intragraft DPP IV inhibition attenuates post-transplant pulmonary ischemia/reperfusion injury after extended ischemia J Heart Lung Transplant 26 2007 174 180
211. W. Zhai, W. Jungraithmayr, I. De Meester, I. Inci, K. Augustyns, and S. Arni Primary graft dysfunction in lung transplantation: the role of CD26/dipeptidylpeptidase IV and vasoactive intestinal peptide Transplantation 87 2009 1140 1146
212. D. Zhang, W. Huang, B. Dai, T. Zhao, A. Ashraf, and R.W. Millard Genetically manipulated progenitor cell sheet with diprotin A improves myocardial function and repair of infarcted hearts Am J Physiol Heart Circ Physiol 299 2010 H1339 H1347
213. G. Zhang, Y. Nakamura, X. Wang, Q. Hu, L.J. Suggs, and J. Zhang Controlled release of stromal cell-derived factor-1 alpha in situ increases c-kit+ cell homing to the infarcted heart Tissue Eng 13 2007 2063 2071
214. T. Zhao, P. Parikh, S. Bhashyam, H. Bolukoglu, I. Poornima, and Y.T. Shen Direct effects of glucagon-like peptide-1 on myocardial contractility and glucose uptake in normal and postischemic isolated rat hearts J Pharmacol Exp Ther 317 2006 1106 1113
215. T. Zhao, D. Zhang, R.W. Millard, M. Ashraf, and Y. Wang Stem cell homing and angiomyogenesis in transplanted hearts are enhanced by combined intramyocardial SDF-1alpha delivery and endogenous cytokine signaling Am J Physiol Heart Circ Physiol 296 2009 H976 H986
216. Y.R. Zou, A.H. Kottmann, M. Kuroda, I. Taniuchi, and D.R. Littman Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development Nature 393 1998 595 599
217. Z. Zukowska, D.S. Grant, and E.W. Lee Neuropeptide Y: a novel mechanism for ischemic angiogenesis Trends Cardiovasc Med 13 2003 86 92